Animalcare Group Plc (ANCR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Animalcare Group Plc (ANCR) has a cash flow conversion efficiency ratio of 0.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX6.12 Million ≈ $744.51 USD) by net assets (GBX114.54 Million ≈ $13.94K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Animalcare Group Plc (ANCR) net asset quality to measure how much of total assets are equity-financed.
Animalcare Group Plc - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Animalcare Group Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Animalcare Group Plc to evaluate the quality of earnings relative to operating cash generation.
Animalcare Group Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Animalcare Group Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Power REIT
NYSE MKT:PW
|
-0.035x |
|
AH-Vest Limited
JSE:AHL
|
-0.211x |
|
Falcon Gold Corp
V:FG
|
-0.004x |
|
Next Mediaworks Limited
NSE:NEXTMEDIA
|
0.011x |
|
TT Electronics Plc
LSE:TTG
|
0.204x |
|
Goenka Diamond and Jewels Limited
NSE:GOENKA
|
0.000x |
|
Ragusa Minerals Ltd
AU:RAS
|
-0.314x |
|
Petrotal Corp
LSE:PTAL
|
0.013x |
Annual Cash Flow Conversion Efficiency for Animalcare Group Plc (2005–2025)
The table below shows the annual cash flow conversion efficiency of Animalcare Group Plc from 2005 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Animalcare Group Plc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | GBX114.54 Million ≈ $13.94K |
GBX10.92 Million ≈ $1.33K |
0.095x | -9.50% |
| 2024-12-31 | GBX113.31 Million ≈ $13.79K |
GBX11.93 Million ≈ $1.45K |
0.105x | -20.21% |
| 2023-12-31 | GBX77.89 Million ≈ $9.48K |
GBX10.28 Million ≈ $1.25K |
0.132x | +10.56% |
| 2022-12-31 | GBX78.99 Million ≈ $9.61K |
GBX9.43 Million ≈ $1.15K |
0.119x | -32.92% |
| 2021-12-31 | GBX78.80 Million ≈ $9.59K |
GBX14.02 Million ≈ $1.71K |
0.178x | +30.61% |
| 2020-12-31 | GBX81.59 Million ≈ $9.93K |
GBX11.12 Million ≈ $1.35K |
0.136x | -14.87% |
| 2019-12-31 | GBX81.89 Million ≈ $9.96K |
GBX13.11 Million ≈ $1.59K |
0.160x | +86.52% |
| 2018-12-31 | GBX86.59 Million ≈ $10.54K |
GBX7.43 Million ≈ $904.02 |
0.086x | +305.48% |
| 2017-12-31 | GBX89.64 Million ≈ $10.91K |
GBX1.90 Million ≈ $230.81 |
0.021x | -79.16% |
| 2017-06-30 | GBX23.84 Million ≈ $2.90K |
GBX2.42 Million ≈ $294.57 |
0.102x | -44.73% |
| 2016-06-30 | GBX22.52 Million ≈ $2.74K |
GBX4.14 Million ≈ $503.23 |
0.184x | -0.92% |
| 2015-06-30 | GBX20.99 Million ≈ $2.55K |
GBX3.89 Million ≈ $473.54 |
0.185x | +238.04% |
| 2014-06-30 | GBX19.45 Million ≈ $2.37K |
GBX1.07 Million ≈ $129.82 |
0.055x | -65.20% |
| 2013-06-30 | GBX17.96 Million ≈ $2.19K |
GBX2.83 Million ≈ $344.45 |
0.158x | +25.00% |
| 2012-06-30 | GBX16.84 Million ≈ $2.05K |
GBX2.12 Million ≈ $258.31 |
0.126x | -7.19% |
| 2011-06-30 | GBX15.79 Million ≈ $1.92K |
GBX2.15 Million ≈ $260.98 |
0.136x | -1.19% |
| 2010-06-30 | GBX14.08 Million ≈ $1.71K |
GBX1.94 Million ≈ $235.56 |
0.137x | -13.08% |
| 2009-06-30 | GBX15.38 Million ≈ $1.87K |
GBX2.43 Million ≈ $296.03 |
0.158x | +61.42% |
| 2008-06-30 | GBX14.64 Million ≈ $1.78K |
GBX1.44 Million ≈ $174.60 |
0.098x | -38.89% |
| 2007-06-30 | GBX6.14 Million ≈ $746.70 |
GBX984.00K ≈ $119.72 |
0.160x | +44.40% |
| 2006-06-30 | GBX5.82 Million ≈ $707.88 |
GBX646.00K ≈ $78.60 |
0.111x | +215.62% |
| 2005-06-30 | GBX5.68 Million ≈ $691.70 |
GBX200.00K ≈ $24.33 |
0.035x | -- |
About Animalcare Group Plc
Animalcare Group plc develops, sells, and distributes licensed veterinary pharmaceuticals for the companion animal, production animal, and equine veterinary markets in Europe, the Asia-Pacific, and internationally. It operates through Animalcare Europe and Randlab segments. The company offers Orozyme, an enzymatic toothpaste for dental care in cats and dogs; Danilon, an oral treatment for pain in… Read more